The global veterinary biologics market is projected to witness robust growth, reaching a valuation of USD 13,140.6 million in 2024 and soaring to an estimated USD 24,224.3 million by 2034. This growth is underpinned by a promising compound annual growth rate (CAGR) of 6.3% over the forecast period from 2024 to 2034.